02.22.22
Galderma and Taro Pharmaceutical Industries Ltd. have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company. The agreement includes Alchemee’s business and assets around the world, including the Proactiv brand. Financial terms have not been disclosed.
Proactiv has been treating skin for more than a quarter century.
The Proactiv Company rebranded as Alchemee in Q4 2021. Earlier this month, Alchemee rolled out a new hyperpigmentation-focused skincare brand called Restorative Elements.
“We are proud of the work we have done together to serve customers suffering from acne around the world through Proactiv. I am confident that Taro is the right owner to build on Alchemee’s strong foundation. Their vision is aligned to Alchemee, which comes with an incredible legacy and brand equity, and a great team with a clear plan for future success,” Fleming Ørnskov, CEO of Galderma, said in a statement today when the accord was announced.
The acquisition is subject to customary closing conditions and any necessary regulatory approvals.
Galderma is the world’s largest independent dermatology company, selling products that reach across aesthetics, consumer care and prescription medicine. Its consumer brands include Cetaphil, Alastin and Differin.
Taro Pharmaceutical Industries Ltd. is a multinational pharmaceutical company. In the US, it sells a number of topical OTC skin treatments such as hydrocortisone creams and antibiotic ointments as well as oral treatments for pain relief and cough and cold.
Proactiv has been treating skin for more than a quarter century.
“We are proud of the work we have done together to serve customers suffering from acne around the world through Proactiv. I am confident that Taro is the right owner to build on Alchemee’s strong foundation. Their vision is aligned to Alchemee, which comes with an incredible legacy and brand equity, and a great team with a clear plan for future success,” Fleming Ørnskov, CEO of Galderma, said in a statement today when the accord was announced.
The acquisition is subject to customary closing conditions and any necessary regulatory approvals.
Galderma is the world’s largest independent dermatology company, selling products that reach across aesthetics, consumer care and prescription medicine. Its consumer brands include Cetaphil, Alastin and Differin.
Taro Pharmaceutical Industries Ltd. is a multinational pharmaceutical company. In the US, it sells a number of topical OTC skin treatments such as hydrocortisone creams and antibiotic ointments as well as oral treatments for pain relief and cough and cold.
